Co Don AG operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Co Don AG with three other
pharmaceutical manufacturers in Europe:
Nuevolution AB (publ)
sales of 29.73 million Swedish Kronor [US$3.33 million]
(5.62 million Euro [US$6.11 million]
based in the United Kingdom
(£3.25 million [US$3.96 million]
of which 62%
Co Don AG reported sales of 5.09 million Euro (US$5.53 million)
December of 2015.
increase of 13.6%
versus 2014, when the company's sales were 4.48 million Euro.
Sales at Co Don AG have increased during each of the previous five years
(and since 2010, sales have increased a total of 137%).